Royalty Report: Drugs, Therapeutic, Disease – Collection: 26844

$100.00

Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 5

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 5

Primary Industries

  • Drugs
  • Therapeutic
  • Disease
  • Pharmaceuticals
  • Biotechnology
  • Cancer
  • DNA
  • Veterinary

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 26844

License Grant
The U.K. pharmaceutical Company hereby grants to the England Licensee, to the extent of the Field for the Territory, an exclusive license to make, have made, use and sell Product(s), provided the Licensee sells Product(s) under existing Licensor trade-marks or under new trade-mark(s) to be agreed by both parties and the terms of clause 6H shall apply to such new trade-mark(s).
License Property
Invention means patented and unpatented, patentable and unpatentable, proprietary technology (Technology) related to a dehydrogenase inhibitor and receptor blocker-the lead compound is Modrefen (a selective steroid receptor modulator), used in the treatment of post-menopausal breast cancer and certain adrenal disorders, such as Cushing’s disease, developed by or on behalf of Licensor, that is (I) related to human.  In clinical trials.
Field of Use
Field means, and is limited to, the practice of the Patent, Invention and Technical information  licensed hereunder for use in human and animal health applications.

IPSCIO Record ID: 26843

License Grant
The English Company hereby grants to the England Licensee, to the extent of the Field for the Territory, an exclusive license to make, have made, use and sell Product(s), provided the Licensee sells Product(s) under existing trade-marks or under new trade-mark(s) to be agreed by both parties and the terms of clause 6H shall apply to such new trade-mark(s).
License Property
Invention means patented and unpatented, patentable and unpatentable, proprietary technology (Technology related to a cell-based vector system for use in gene therapy and related technologies such as stem cell cryopreservation that is (I) related to human and animal health applications of the Technology or (ii) necessary for the practice of Technology for human and animal health applications as disclosed and claimed in the Patent(s).  In clinical trials.
Field of Use
Field means, and is limited to, the practice of the Patent, Invention and Technical  information  licensed hereunder for use in human and animal  health applications.

IPSCIO Record ID: 154604

License Grant
The  parties to this Agreement hereby agree to jointly co-develop the Technology according to the terms of this Agreement which supersedes the 'Heads of Terms for a Co-Development Agreement' set forth and all other written or verbal agreements, express or implied, between Licensor and Licensee relating to co-development of the Technology.

Licensor hereby grants to Licensee, to the extent of the Field for the Territory, an exclusive  license to make,  have made, use and sell Product(s), provided Licensee sells Product(s) under existing Licensor trade-marks or under new trade-mark(s) to be agreed by both parties and the terms of clause 6H shall apply to such new trademark(s).

Licensor hereby grants to Licensee, to the extent of the Field for the Territory, an exclusive license to use the Technical Information necessary to practice the Technology such that Licensee may make, have made, use and sell Product(s).

License Property
Product means a product, service, test, or information which is sold or provided for a fee and but for the license  granted herein would infringe one or more claims of a Patent, or was discovered, developed, approved, manufactured or marketed using an Invention, Improvement or Technical Information.

Invention means patented and unpatented, patentable and unpatentable, proprietary technology (Technology) related to DNA vectors for the treatment of liver insufficiency, with particular reference to the treatment of hypoalbuminaemia, developed by or on behalf of Licensee, that is (i) related to human and animal health applications of the Technology or (ii) necessary for the practice of Technology for human and animal health  applications as disclosed and claimed in the Patent(s).

Licensed Technology means the Patent, Improvement, and Technical Information relating to human and animal health applications of the Technology or Product(s).

Patent means the patents and/or patent applications, covering the Technology, Product(s), Invention or improvement as defined above.

Field of Use
This agreement pertains to the drug industry relating to the field which means, and is limited to, the practice of the Patent, Invention and Technical information licensed hereunder for use in human and animal health applications.

Hypoalbuminemia (or hypoalbuminaemia) is a medical sign in which the level of albumin in the blood is abnormally low.

IPSCIO Record ID: 27498

License Grant
A subsidiary of the Company entered into an agreement with the Chairman of the Board and Chief Executive Officer of the Company, to co-develop a gene marker and immunomodulator system for use in gene therapy and related technologies.  Licensee was granted the exclusive license to make, use and sell products derived from technology, and to utilize technical information related to the technology to obtain patent and other proprietary rights to products – clinical trial.
License Property
Licensor Wood has rights in patents and technical information relating to the development and uses of a a gene marker and immunomodulator system for use in gene therapy and related technologies.

Invention means patented and unpatented, patentable and unpatentable, proprietary technology ('Technology') related to a cell-based vector system for use in gene therapy and related technologies, developed by or on behalf of Licensor, that is (i) related to human and animal health applications of the Technology or (ii) necessary for the practice of Technology for human and animal health applications as disclosed and claimed in the Patent(s).

Field of Use
Field means, and is limited to, the practice of the Patent, Invention and Technical information licensed hereunder for use in human and animal health applications.

IPSCIO Record ID: 5875

License Grant
Licensor hereby grants to Licensee and its Affiliates of England an exclusive license of the Licensed Assets, including a sublicense under the Co-Development Agreement.
License Property
Licensor has certain rights and entitlements, in its own name, in and to trilostane and methods of using trilostane.

Licensor has entered into a Co-Development Agreement dated July 15, 1998 which granted to Licensor certain rights and entitlements (including the marketing and development rights) in and to the chemical compound known as trilostane, an inhibitor of 3a-hydroxysteroid dehydrogenase, and methods of using trilostane.

The drug is an animal health product, Vetoryl® (trilostane) the treatment of Cushing’s disease in dogs.

Field of Use
Licensed Field shall mean, and is limited to, the practice of the Licensed Patents, Licensed Inventions and Licensed Technical Information, in each case, solely for use in animal health applications.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.